Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

April 1, 2021

Conditions
Dentin HypersensitivityActive Dental Caries
Interventions
DRUG

38% Silver Fluoride and Potassium Iodide solution (generic name; Riva Star®)

38% silver fluoride will be applied to the surface of the isolated hypersensitive carious lesion followed by application of potassium iodide solution and according to manufacturer's instructions.

DRUG

Sodium fluoride varnish (generic name; Duraphat®)

22,600 ppm sodium fluoride varnish will be applied on the surface of the affected hypersensitive active carious lesions.

Trial Locations (1)

17475

The Department of Preventive and Pediatric Dentistry, University of Greifswald, Greifswald

All Listed Sponsors
collaborator

SDI Limited

UNKNOWN

lead

University Medicine Greifswald

OTHER

NCT04804423 - Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth | Biotech Hunter | Biotech Hunter